Tourmaline Bio
Tory Trippe is currently the Senior Director of Finance and Corporate Development at Tourmaline Bio. Prior to this role, Trippe held various finance and business development positions at companies like Roivant Sciences and Alexion Pharmaceuticals. Trippe's early career includes internships in business development and commercial advisory services, along with roles as a summer biology intern and summer intern. Trippe holds a Bachelor's degree in Applied Economics and Management and Biological Sciences from Cornell University.
Tourmaline Bio
2 followers
Tourmaline is a late-stage clinical biotechnology company driven by our mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune and inflammatory diseases. In doing so, we seek to develop assets medicines that have the potential to establish new standards-of-care in areas of high unmet medical need.